peptide

PT-141

Libidoalso known as Bremelanotide, Vyleesi

A cyclic synthetic peptide derived from Melanotan II, acting on melanocortin receptors (MC3R and MC4R).

FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Mechanism is centrally mediated through the central nervous system rather than vascular, distinguishing it from PDE5 inhibitors.

27 vendors with finnrick test grades. Higher grade = higher confirmed purity. Pricing data is pending for this peptide — grades below reflect independent purity testing.

#VendorGradeScoreTestsReputation
1
Great
A9.9275
2
Great
A9.8476
3
Great
A9.5291
4
Great
A9.1666
5
Great
A8.9283
6
Great
A8.3671
7
Polaris Peptideslogin required
Great
A7.4673
8
Great
A7.4372
9
Utherflag
Good
B8.3474
10
Good
B6.5470
11
Okay
C8.0367
12
Okay
C6.9574
13
Okay
C6.5477
14
Okay
C5.8281
15
Okay
C5.8233
16
Okay
C5.7271
17
Okay
C5.7266
18
Okay
C5.7360
19
Poor
D7.5769
20
Poor
D5.9441
21
Poor
D5.2254
22
Fraud
F8.6570
23
Unrated
X4.7167
24
Unrated
X2.5157
25
Bad
E5.9874
26
Bad
E3.0336
27
Bad
E2.2264

Grades sourced from finnrick.com. Grade A = highest confidence in purity based on independent lab testing. Score is averaged across 95 individual tests.